FIELD: medicine.
SUBSTANCE: group of inventions relates to field of medicine. Diagnostics of subject, which is in condition of transient cerebral hypoxia and/or ischemia, including those caused by brain trauma, is performed. Not later, than after 16 hours after development of said condition, therapeutically efficient quantity of methamphetamine is introduced to subject.
EFFECT: application of claimed group of inventions makes it possible to efficiently reduce frequency of damage to nervous cells, caused by transient cerebral hypoxia and/or ischemia.
15 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 7-HYDROXYEPIANDROSTERON WITH NEUROPROTECTIVE ACTIVITY | 2001 |
|
RU2307654C2 |
| METHOD FOR PREVENTING ISCHEMIC AND REPERFUSION INJURIES OF THE HIPPOCAMPUS NEURONS IN THE POSTRESUSCITATIVE PERIOD | 2019 |
|
RU2707875C1 |
| ESTROGEN COMPONENTS FOR APPLICATION IN NEUROLOGICAL DISORDERS TREATMENT | 2013 |
|
RU2627846C2 |
| METHOD FOR TREATING ISCHEMIA AND CEREBRAL LESION WITH A NEUROPROTECTOR PREPARATION | 1996 |
|
RU2194527C2 |
| METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
| NOVEL DERIVATIVES OF CYCLOALKANEDIONE, METHOD FOR THEIR PREPARING AND THEIR USING IN PHARMACEUTICS | 2003 |
|
RU2322445C2 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| TREATMENT OF NEUROLOGICAL DYSFUNCTION BY USING FRUCTOPYRANOSE AND ERYTHROPOIETIN SULFAMATES | 2002 |
|
RU2317086C2 |
| METHOD OF TREATING NEUROLOGICAL DISORDERS | 2008 |
|
RU2492137C2 |
| DRUG FOR NEUROPROTECTION (VARIANTS) | 1994 |
|
RU2135162C1 |
